Literature DB >> 10363650

Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism.

P O Hasselgren1.   

Abstract

Several lines of evidence suggest that the ubiquitin-proteasome pathway is involved in sepsis-induced muscle catabolism. The gene expression of ubiquitin and several of the proteasome subunits was increased in muscle from both septic rats and patients. In other studies, the activity of isolated 20S proteasomes was stimulated in septic muscles. Sepsis-induced increase in muscle total and myofibrillar protein breakdown was inhibited with specific proteasome blockers. Although the ubiquitin-proteasome pathway is upregulated in septic muscle, it is still unclear how the myofibrillar proteins actin and myosin are ubiquitinated and become substrates for the 26S proteasome. Recent studies suggest that a calcium-dependent, calpain-mediated process releases myofilaments from the Z-disks during sepsis. It is possible that this process exposes destabilizing N-terminal residues on actin and myosin, making them suitable substrates for the N-end rule pathway involving the 14 kD ubiquitin-conjugating enzyme E214k and the ubiquitin-protein ligase E3alpha.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363650     DOI: 10.1023/a:1006916206260

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

Review 1.  The N-end rule pathway of protein degradation.

Authors:  A Varshavsky
Journal:  Genes Cells       Date:  1997-01       Impact factor: 1.891

2.  Increased synthesis of secreted hepatic proteins during abdominal sepsis.

Authors:  H C Sax; M A Talamini; P O Hasselgren; L Rosenblum; C K Ogle; J E Fischer
Journal:  J Surg Res       Date:  1988-02       Impact factor: 2.192

3.  Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients.

Authors:  O Mansoor; B Beaufrere; Y Boirie; C Ralliere; D Taillandier; E Aurousseau; P Schoeffler; M Arnal; D Attaix
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

4.  Glucocorticoids do not regulate the expression of proteolytic genes in skeletal muscle from Cushing's syndrome patients.

Authors:  C Rallière; I Tauveron; D Taillandier; L Guy; J P Boiteux; B Giraud; D Attaix; P Thiéblot
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

5.  Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids.

Authors:  D Auclair; D R Garrel; A Chaouki Zerouala; L H Ferland
Journal:  Am J Physiol       Date:  1997-03

6.  Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes.

Authors:  W E Mitch; R Medina; S Grieber; R C May; B K England; S R Price; J L Bailey; A L Goldberg
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  The mouse and human genes encoding the recognition component of the N-end rule pathway.

Authors:  Y T Kwon; Y Reiss; V A Fried; A Hershko; J K Yoon; D K Gonda; P Sangan; N G Copeland; N A Jenkins; A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

8.  Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids.

Authors:  G Tiao; J Fagan; V Roegner; M Lieberman; J J Wang; J E Fischer; P O Hasselgren
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

9.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.

Authors:  G Fenteany; R F Standaert; W S Lane; S Choi; E J Corey; S L Schreiber
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

10.  The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway.

Authors:  J L Bailey; X Wang; B K England; S R Price; X Ding; W E Mitch
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

View more
  8 in total

Review 1.  Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation.

Authors:  P O Hasselgren; J E Fischer
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

2.  The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation.

Authors:  Gerald S Supinski; Xinying Ji; Leigh Ann Callahan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

3.  Eicosapentaenoic acid preserves diaphragm force generation following endotoxin administration.

Authors:  Gerald S Supinski; Jonas Vanags; Leigh Ann Callahan
Journal:  Crit Care       Date:  2010-03-16       Impact factor: 9.097

Review 4.  Biomedical consequences of alcohol use disorders in the HIV-infected host.

Authors:  Patricia E Molina; Gregory J Bagby; Steve Nelson
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

5.  Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.

Authors:  G S Supinski; J Vanags; L A Callahan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-17       Impact factor: 5.464

6.  Calpain activation contributes to endotoxin-induced diaphragmatic dysfunction.

Authors:  Gerald S Supinski; Leigh Ann Callahan
Journal:  Am J Respir Cell Mol Biol       Date:  2009-03-27       Impact factor: 6.914

7.  Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats.

Authors:  Qiyi Chen; Ning Li; Weiming Zhu; Weiqin Li; Shaoqiu Tang; Wenkui Yu; Tao Gao; Juanjuan Zhang; Jieshou Li
Journal:  J Inflamm (Lond)       Date:  2011-06-03       Impact factor: 4.981

Review 8.  Alcohol and HIV Effects on the Immune System.

Authors:  Gregory J Bagby; Angela M Amedee; Robert W Siggins; Patricia E Molina; Steve Nelson; Ronald S Veazey
Journal:  Alcohol Res       Date:  2015
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.